289 related articles for article (PubMed ID: 25065884)
1. Assays for necroptosis and activity of RIP kinases.
Degterev A; Zhou W; Maki JL; Yuan J
Methods Enzymol; 2014; 545():1-33. PubMed ID: 25065884
[TBL] [Abstract][Full Text] [Related]
2. Coordinated ubiquitination and phosphorylation of RIP1 regulates necroptotic cell death.
de Almagro MC; Goncharov T; Izrael-Tomasevic A; Duttler S; Kist M; Varfolomeev E; Wu X; Lee WP; Murray J; Webster JD; Yu K; Kirkpatrick DS; Newton K; Vucic D
Cell Death Differ; 2017 Jan; 24(1):26-37. PubMed ID: 27518435
[TBL] [Abstract][Full Text] [Related]
3. High-mobility group box 1 protein-mediated necroptosis contributes to dasatinib-induced cardiotoxicity.
Xu Z; Jin Y; Yan H; Gao Z; Xu B; Yang B; He Q; Shi Q; Luo P
Toxicol Lett; 2018 Oct; 296():39-47. PubMed ID: 30086328
[TBL] [Abstract][Full Text] [Related]
4. RIP1/RIP3-regulated necroptosis as a target for multifaceted disease therapy (Review).
Liu Y; Liu T; Lei T; Zhang D; Du S; Girani L; Qi D; Lin C; Tong R; Wang Y
Int J Mol Med; 2019 Sep; 44(3):771-786. PubMed ID: 31198981
[TBL] [Abstract][Full Text] [Related]
5. Necroptosis in cancer: An angel or a demon?
Wang T; Jin Y; Yang W; Zhang L; Jin X; Liu X; He Y; Li X
Tumour Biol; 2017 Jun; 39(6):1010428317711539. PubMed ID: 28651499
[TBL] [Abstract][Full Text] [Related]
6. Extracts derived from a traditional Chinese herbal formula triggers necroptosis in ectocervical Ect1/E6E7 cells through activation of RIP1 kinase.
Chen X; Hu X; Liu L; Liang X; Xiao J
J Ethnopharmacol; 2019 Jul; 239():111922. PubMed ID: 31034957
[TBL] [Abstract][Full Text] [Related]
7. Necroptosis: an emerging form of programmed cell death.
Wu W; Liu P; Li J
Crit Rev Oncol Hematol; 2012 Jun; 82(3):249-58. PubMed ID: 21962882
[TBL] [Abstract][Full Text] [Related]
8. Does necroptosis have a crucial role in hepatic ischemia-reperfusion injury?
Saeed WK; Jun DW; Jang K; Chae YJ; Lee JS; Kang HT
PLoS One; 2017; 12(9):e0184752. PubMed ID: 28957350
[TBL] [Abstract][Full Text] [Related]
9. Evidence of necroptosis in hearts subjected to various forms of ischemic insults.
Adameova A; Hrdlicka J; Szobi A; Farkasova V; Kopaskova K; Murarikova M; Neckar J; Kolar F; Ravingerova T; Dhalla NS
Can J Physiol Pharmacol; 2017 Oct; 95(10):1163-1169. PubMed ID: 28472590
[TBL] [Abstract][Full Text] [Related]
10. CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis.
Zhang T; Zhang Y; Cui M; Jin L; Wang Y; Lv F; Liu Y; Zheng W; Shang H; Zhang J; Zhang M; Wu H; Guo J; Zhang X; Hu X; Cao CM; Xiao RP
Nat Med; 2016 Feb; 22(2):175-82. PubMed ID: 26726877
[TBL] [Abstract][Full Text] [Related]
11. Distinct roles of RIP1-RIP3 hetero- and RIP3-RIP3 homo-interaction in mediating necroptosis.
Wu XN; Yang ZH; Wang XK; Zhang Y; Wan H; Song Y; Chen X; Shao J; Han J
Cell Death Differ; 2014 Nov; 21(11):1709-20. PubMed ID: 24902902
[TBL] [Abstract][Full Text] [Related]
12. Complex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis.
Wegner KW; Saleh D; Degterev A
Trends Pharmacol Sci; 2017 Mar; 38(3):202-225. PubMed ID: 28126382
[TBL] [Abstract][Full Text] [Related]
13. The role of the kinases RIP1 and RIP3 in TNF-induced necrosis.
Vandenabeele P; Declercq W; Van Herreweghe F; Vanden Berghe T
Sci Signal; 2010 Mar; 3(115):re4. PubMed ID: 20354226
[TBL] [Abstract][Full Text] [Related]
14. Connections between various trigger factors and the RIP1/ RIP3 signaling pathway involved in necroptosis.
Zhang YY; Liu H
Asian Pac J Cancer Prev; 2013; 14(12):7069-74. PubMed ID: 24460252
[TBL] [Abstract][Full Text] [Related]
15. Dichotomy between Receptor-Interacting Protein 1- and Receptor-Interacting Protein 3-Mediated Necroptosis in Experimental Pancreatitis.
Wu J; Mulatibieke T; Ni J; Han X; Li B; Zeng Y; Wan R; Wang X; Hu G
Am J Pathol; 2017 May; 187(5):1035-1048. PubMed ID: 28315674
[TBL] [Abstract][Full Text] [Related]
16. Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury.
Linkermann A; Bräsen JH; Himmerkus N; Liu S; Huber TB; Kunzendorf U; Krautwald S
Kidney Int; 2012 Apr; 81(8):751-61. PubMed ID: 22237751
[TBL] [Abstract][Full Text] [Related]
17. Molecular Pathways: The Necrosome-A Target for Cancer Therapy.
Seifert L; Miller G
Clin Cancer Res; 2017 Mar; 23(5):1132-1136. PubMed ID: 27932417
[TBL] [Abstract][Full Text] [Related]
18. Receptor interacting protein 3-induced RGC-5 cell necroptosis following oxygen glucose deprivation.
Ding W; Shang L; Huang JF; Li N; Chen D; Xue LX; Xiong K
BMC Neurosci; 2015 Aug; 16():49. PubMed ID: 26238997
[TBL] [Abstract][Full Text] [Related]
19. Increased hepatic receptor interacting protein kinase 3 expression due to impaired proteasomal functions contributes to alcohol-induced steatosis and liver injury.
Wang S; Ni HM; Dorko K; Kumer SC; Schmitt TM; Nawabi A; Komatsu M; Huang H; Ding WX
Oncotarget; 2016 Apr; 7(14):17681-98. PubMed ID: 26769846
[TBL] [Abstract][Full Text] [Related]
20. Sorafenib tosylate inhibits directly necrosome complex formation and protects in mouse models of inflammation and tissue injury.
Martens S; Jeong M; Tonnus W; Feldmann F; Hofmans S; Goossens V; Takahashi N; Bräsen JH; Lee EW; Van der Veken P; Joossens J; Augustyns K; Fulda S; Linkermann A; Song J; Vandenabeele P
Cell Death Dis; 2017 Jun; 8(6):e2904. PubMed ID: 28661484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
